AND SOLUTIONS GRADED A+
✔✔What conditions must be met for a pharmacy to obtain a veterinary pharmacy
permit? - ✔✔1) Pharmacy will follow the law
2) Equipment and facilities are safe
3) Equipped with proper sanitary and pharmaceutical devices
4) management of pharmacy is under the supervision of either a registered pharmacist,
or an owner or employee of the owner, who has at his or her place of business a
registered pharmacist employed for the purpose of compounding physician's or
veterinarian's prescriptions in the event any such prescriptions are compounded or sold
✔✔Can a pharmacy permit holder with a class L license work without supervision? -
✔✔As long as they designate a supervising registered pharmacist who shall be
responsible for reviewing the activities and records of the class L pharmacy permit
holder. The supervising registered pharmacist shall not be required to be physically
present on site during the business operations of a class L pharmacy permit holder
identified in subdivision (5) of subsection 1 of this section when noncontrolled legend
drugs
✔✔Who determines the minimum technical equipment required for a pharmacy? -
✔✔the board
✔✔Is there a minimum inventory requirement for MO pharmacies? - ✔✔No
✔✔When will application blanks for renewal permits be mailed to each permittee? -
✔✔on or before the first day of the month in which the permit expires
✔✔At what point does an existing permit or renewal lapse and become null and void? -
✔✔If the renewal of permit is not made before the first day of the month following the
expiration of the permit, the permit becomes null and void upon the last day of that
month.
✔✔What happens if the pharmacy is not being conducted lawfully and is noted upon
inspection? - ✔✔The board can file a complaint with the administrative hearing
commission
✔✔Where should the pharmacy's permit be displayed? Is it transferable? -
✔✔Conspicuously; no
✔✔Can the board inspect a LTCF? - ✔✔Only the licensed pharmacy inside it
, ✔✔What happens to someone who is caught purchasing legend drugs from a non-
licensed/non-registered distributor? - ✔✔Class A misdemeanor first time, then Class D
felony if it happens again
✔✔What volume of drugs can be purchased or transferred from other pharmacies? -
✔✔5% or less of pharmacy's total annual sales
✔✔How long must receipts of drugs transferred between pharmacies be kept? - ✔✔at
least 2 years
✔✔What is designed to facilitate, monitor, and report to the general assembly on
Missouri-based efforts to contribute to the establishment of national electronic prior
authorization standards? - ✔✔"Missouri Electronic Prior Authorization Committee"
✔✔Who makes up the "Missouri Electronic Prior Authorization Committee"? - ✔✔1) 2
senate members
2) 2 house of representatives members
3) 1 member from organization of licensed physicians
4) 1 MO physicians
5) 1 MO PBM representative
6) 1 MO licensed pharmacist
7) 1 member representing business on health insurance rates
8) 1 member from research-based pharm biotechnology companies
9) 1 member from the largest generic pharmaceutical trade association
10) 1 patient advocate
11) 1 member from an electronic prescription network that facilitates the secure
electronic exchange
12) 1 member from MO-based electronic health records company
13) 1 member representing largest MO hospitals
14) 1 member from a health carrier
15) 1 member from an organization representing the largest number of health carriers in
the state
16) The director of the department of social services, or the director's designee
17) The director of the department of insurance, financial institutions and professional
registration, who shall be chair of the committee
✔✔Who appoints the members of MEPAC? - ✔✔The governor
✔✔Who sets forth the national electronic prior authorization standards - ✔✔NCPDP
✔✔What is the purpose of Missouri Oral Chemotherapy Parity Interim Committee? -
✔✔to study the disparity in patient co-payments between orally and intravenously
administered chemotherapies, the reasons for the disparity, and the patient benefits in
establishing co-payment parity between oral and infused chemotherapy agents